Sixteen analysts covering NYSE: OHI stock’s performance announced in a report issued this week that the Omega Healthcare Investors, Inc. gets a consensus rating of “Buy” from the brokerages.
Among the sixteen who have posted their ratings on the company, one gave a “Sell” rating, three analysts have given out a “Hold” rating. A majority of nine analysts have assigned the rating of “Buy” to the stock. The average price target (PT) currently stands at $35.53 issued on the stock last year.
Omega Healthcare Investors, Inc. stocks traded at $37.14 this Friday. The company’s current market capitalization stands at $8.61 billion. It has a positive PE ratio of 53.83 along with a beta of 1.03 at the moment. The PEG ratio stands at 2.47. Along with this, the company’s current ratio is 3.40, the quick ratio is 3.40 and the debt-to-equity ratio is 1.31. The 12-monthly high to low ranges from $43.62 to $13.33. The 50SMA (50 Days Simple Moving Average) stands at $36.56 and its 200SMA stands at $33.97
NYSE: OHI Stock Detailed Analysis
The quarterly earnings report for the previous quarter was released on the 4th of February. The earnings of OHI stocks stood at $0.27 EPS matching the general consensus of $0.79 proposed by analysts at several research firms. The company’s return on equity stands at 3.78% along with a net margin of 17.99%. Analysts expect the company to post Full Year 2020 earnings per share of 3.15. According to the latest sources, shareholders were paid a quarterly dividend of $0.67 per share on the 16th of February. This suggests a dividend yield of 7.22% and an annualized dividend of $2.68.
NYSE: OHI has recently been the subject of a lot of reports by equities analysts. Some such as Wells Fargo & Company, Citigroup, Bank Of America, Mizuho, Jefferies Financial Group and so on have posted reports on this firm over the last few months.
